Comparative statistics by cancer registry
Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
(Izmir, Turkey, 1995-1997 cases followed-up until 2003)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | Total | Absolute survival % | Relative survival % | ASRS% at 5-years | ||||||
| 1-year | 3-year | 5-year | 1-year | 3-year | 5-year | all ages | 0-74 years | ||||
| C18 | Colon | 371 | 73.8 | 53.6 | 44.9 | 76.0 | 58.7 | 52.5 | 53.2 | 52.2 | |
| C19-20 | Rectum | 344 | 82.9 | 55.9 | 44.1 | 85.0 | 60.1 | 50.4 | 51.6 | 52.0 | |
| C32 | Larynx | 478 | 87.9 | 70.2 | 62.2 | 90.0 | 75.6 | 70.9 | 68.9 | 71.4 | |
| C50 | Breast | 1329 | 96.3 | 81.3 | 71.1 | 97.6 | 84.9 | 76.7 | 76.6 | 77.2 | |
| C53 | Cervix | 246 | 89.7 | 68.2 | 58.8 | 90.7 | 70.5 | 62.3 | 57.6 | 63.5 | |
| C56 | Ovary | 230 | 83.4 | 62.9 | 54.7 | 84.7 | 65.7 | 59.0 | 60.2 | 59.7 | |
| C67 | Urinary bladder | 566 | 84.7 | 67.3 | 57.7 | 87.7 | 75.1 | 69.7 | 69.9 | 70.7 | |
| C81 | Hodgkin lymphoma | 85 | 92.5 | 77.4 | 65.6 | 93.3 | 79.3 | 68.6 | 67.9 | 65.8 | |
| C82-85+C96 | Non-Hodgkin lymphoma | 344 | 72.6 | 51.0 | 45.1 | 73.9 | 53.8 | 49.5 | 49.8 | 50.6 | |
| C90 | Multiple myeloma | 79 | 65.8 | 43.0 | 28.5 | 67.3 | 46.2 | 32.3 | 31.6 | 31.1 | |
| C91 | Lymphoid leukaemia | 161 | 78.1 | 55.5 | 48.2 | 79.2 | 57.6 | 51.4 | 52.6 | 50.1 | |
| C92-94 | Myeloid leukaemia | 148 | 65.7 | 41.2 | 29.5 | 67.0 | 43.4 | 32.2 | 33.0 | 34.2 | |
Graphs:
 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Izmir, Turkey, 1995-1997) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |